Skip to main content
. 2021 Mar 22;14:967–981. doi: 10.2147/IJGM.S302012

Figure 1.

Figure 1

Analysis of differential expression, disease progression and diagnostic implications of ARRDC3 in ovarian cancer. (A and B) Differential expression and disease progression of ARRDC3 in ovarian cancer, respectively; (C and D) validation of differential expression of ARRDC3 in GEO and ONCOMINE databases, respectively; (E and F) diagnostic implications of ARRDC3 in GEO and ONCOMINE databases, respectively.

Notes: *P <0.05; **P<0.01.